I85PREP
⌘ K
Licensed Pharmacist Qualification (China) study materials
Licensed Pharmacist Qualification (China) study resources

Licensed Pharmacist Qualification (China) practice questions

One question at a time. Build your Licensed Pharmacist Qualification (China) understanding.

First 50 of 190 questions. Each one lists the choices, the correct answer, and an explanation. The checker at the top of this page saves progress in this browser when it is available.

Continue in the practice tool above to load more questions, 50 at a time.

Question 1Pharmacodynamic targets, class effects and therapeutic limits

From a medicinal chemistry structure-activity relationship (SAR) perspective, what chemical modification in second-generation ACE inhibitors (e.g., Enalapril) eliminated the skin rash and taste disturbance (dysgeusia) adverse effects characteristic of Captopril?

  1. Replacing the proline ring with a morpholine ring.
  2. Incorporating a fluorinated sulfonamide group.
  3. Adding a quaternary ammonium bridge to block blood-brain barrier penetration.
  4. Replacing the zinc-binding sulfhydryl group (-SH / 巯基) with a carboxylate group (dicarboxylate design, formulated as an ethyl ester prodrug). Correct answer.

Explanation

Captopril contains a free sulfhydryl group (-SH / 巯基) that coordinates with the active site Zn2+ ion of Angiotensin-Converting Enzyme (ACE). However, this -SH group is responsible for idiosyncratic adverse effects, including skin rashes, dysgeusia (loss of taste), and proteinuric autoimmune phenomena. Second-generation dicarboxylate ACE inhibitors (such as Enalapril, Ramipril) replaced the sulfhydryl group with a carboxylate group that binds Zn2+, eliminating sulfhydryl-related adverse effects while ethyl-esterification created orally bioavailable prodrugs.

Question 2Pharmacodynamic targets, class effects and therapeutic limits

Regarding the structural characteristics and chemical instability of Penicillin G (Benzylpenicillin), which structural feature is responsible for its rapid degradation in acidic gastric acid and inactivation by bacterial β-lactamases?

  1. The planar aromatic benzyl side chain.
  2. The highly strained, fused four-membered β-lactam ring (β-内酰胺环) fused to a thiazolidine ring. Correct answer.
  3. The free carboxylic acid group at position C-3.
  4. The hydrophobic methyl groups on the thiazolidine ring.

Explanation

Penicillins consist of a four-membered β-lactam ring fused to a five-membered thiazolidine ring (6-aminopenicillanic acid / 6-APA core). The bond angles in the fused bicyclic system diverge from normal sp3 tetrahedral geometry, producing high ring strain (高张力环). In acidic media, neighboring group participation by the side-chain amide carbonyl triggers nucleophilic attack on the β-lactam carbonyl, cleaving the ring. Bacterial β-lactamases also hydrolyze the β-lactam amide bond, destroying antibacterial activity.

Question 3Pharmacokinetics, therapeutic monitoring and explicit calculation models

According to the pH-Partition Hypothesis (pH-分配假说) and Fick's first law of passive diffusion across biological membranes, which physicochemical state of a weak organic acid drug (pKa = 3.5) ensures the highest rate of passive transcellular absorption in the gastric environment (pH = 1.5)?

  1. The fully ionized hydrophilic conjugate base form.
  2. The quaternary ammonium polar complex state.
  3. The non-ionized (分子型 / unionized), lipid-soluble form. Correct answer.
  4. The macromolecular micellar aggregated state.

Explanation

According to the pH-partition theory (pH-分配学说), biological cell membranes are lipid bilayers that preferentially permit the passive transport of non-ionized (molecular), lipophilic drug forms. For a weak acid with pKa = 3.5 in gastric fluid at pH = 1.5, applying the Henderson-Hasselbalch equation (log[Ionized/Unionized] = pH - pKa = 1.5 - 3.5 = -2) reveals that 99% of the drug exists in the unionized (分子型) lipid-soluble form, maximizing passive membrane permeation.

Question 4Pharmacokinetics, therapeutic monitoring and explicit calculation models

In pharmaceutical biotransformation (药物生物转化), which of the following enzymatic metabolic pathways represents a Phase II Conjugation Reaction (II期结合反应)?

  1. Glucuronidation (葡萄糖醛酸结合) mediated by UDP-glucuronosyltransferases (UGTs). Correct answer.
  2. Aromatic ring hydroxylation catalyzed by Cytochrome P450 (CYP450) monooxygenases.
  3. Ester bond hydrolysis catalyzed by plasma carboxylesterases.
  4. Nitro reduction catalyzed by intestinal microbial reductases.

Explanation

Drug metabolism is divided into Phase I (functionalization) and Phase II (conjugation) reactions. Phase I reactions introduce or unmask polar functional groups (-OH, -NH2, -COOH) through oxidation, reduction, or hydrolysis. Phase II reactions conjugate the parent drug or Phase I metabolite with endogenous hydrophilic molecules; Glucuronidation (葡萄糖醛酸结合反应) via UDP-glucuronosyltransferase (UGT) is the most common Phase II pathway, significantly enhancing water solubility for urinary excretion.

Question 5Dosage forms, formulation behavior and responsible preparation

In solid oral dosage form formulation, what functional role do excipients such as Croscarmellose Sodium (交联羧甲基纤维素钠 / CCNa), Sodium Starch Glycolate (羧甲基淀粉钠 / CMS-Na), and Low-Substituted Hydroxypropyl Cellulose (低取代羟丙纤维素 / L-HPC) perform in tablet manufacturing?

  1. Glidants and anti-adherents that reduce die wall friction.
  2. Superdisintegrants (崩解剂) that rapidly swell upon contact with water to break up the compressed tablet. Correct answer.
  3. Hydrophobic binders that retard dissolution to achieve 24-hour zero-order drug release.
  4. Effervescent acidulants that react with carbonate salts to produce carbon dioxide.

Explanation

Croscarmellose Sodium (CCNa), Sodium Starch Glycolate (CMS-Na), and L-HPC are classic superdisintegrants (崩解剂). They exhibit extensive capillary water absorption and rapid volumetric swelling (often swelling hundreds of percent), generating internal expansive forces that rapidly break the compressed tablet matrix into primary granules, facilitating rapid active ingredient dissolution.

Question 6Dosage forms, formulation behavior and responsible preparation

Which of the following formulations represents an Advanced Oral Controlled-Release Delivery System (控释制剂) that achieves constant zero-order (Q = k0 * t) drug release independent of gastrointestinal tract pH, enzymes, and peristaltic motility?

  1. Oral Osmotic Pump Tablets (口服渗透泵片). Correct answer.
  2. Conventional immediate-release compressed tablets (普通压制片).
  3. Gastric juice-soluble enteric film-coated tablets (胃溶包衣片).
  4. Effervescent disintegrating chewable tablets (泡腾咀嚼片).

Explanation

Oral Osmotic Pump Tablets (口服渗透泵片) consist of a drug core containing an osmotic agent enclosed by a rigid semi-permeable membrane (such as cellulose acetate) with laser-drilled delivery orifices. In the GI tract, water permeates through the semi-permeable membrane at a constant rate driven by osmotic pressure, generating hydrostatic pressure inside the core that pumps the drug solution/suspension out of the orifice at a steady zero-order release rate (零级释放) independent of ambient pH or motility.

Question 7Pharmaceutical analysis, identity, stability and quality evidence

In the quality control of sterile injectable preparations under the Chinese Pharmacopoeia (ChP), what is the biochemical principle of the Bacterial Endotoxin Test (BET / 细菌内毒素检查法)?

  1. Measuring hemolysis of red blood cells caused by Staphylococcus exotoxins.
  2. Coagulation/gelation of Limulus Amebocyte Lysate (TAL / 鲎试剂) triggered by lipopolysaccharide (LPS) from Gram-negative bacterial cell walls. Correct answer.
  3. Measuring the temperature rise in healthy New Zealand white rabbits over 3 hours.
  4. Spectrophotometric detection of nitrogen gas produced by Clostridium sporogenes.

Explanation

The Bacterial Endotoxin Test (BET / 细菌内毒素检查法) uses Limulus/Tachypleus Amebocyte Lysate (TAL / 鲎试剂), an extract of blood cells from the horseshoe crab. Bacterial endotoxin (lipopolysaccharide / LPS derived from the outer cell wall of Gram-negative bacteria) activates an enzymatic coagulation cascade in TAL, producing gelation, turbidity, or chromogenic cleavage proportional to endotoxin concentration.

Question 8Pharmaceutical analysis, identity, stability and quality evidence

Which of the following pharmaceutical compounds contains phenolic hydroxyl or catechol structures and is highly susceptible to chemical degradation via OXIDATION (氧化), requiring the addition of water-soluble antioxidants like Sodium Metabisulfite (焦亚硫酸钠) and amber glass packaging?

  1. Procaine Hydrochloride (盐酸普鲁卡因)
  2. Epinephrine (Adrenaline / 肾上腺素) Correct answer.
  3. Aspirin (Acetylsalicylic acid / 阿司匹林)
  4. Ampicillin Sodium (氨苄西林钠)

Explanation

Epinephrine (肾上腺素) contains an easily oxidizable catechol (邻苯二酚) moiety. Exposure to dissolved oxygen, heavy metal ions, light, or alkaline pH triggers oxidation into adrenochrome and brownish polymeric quinone derivatives, resulting in drug inactivation. To prevent oxidation, formulations require water-soluble antioxidants (such as sodium metabisulfite or sodium bisulfite), metal chelators (EDTA-2Na), inert gas bubbling (N2), and protection from light.

Question 9Medical biology, diagnostic evidence and sample interpretation

In human cellular physiology, which transport mechanism is responsible for moving Na+ out of the cell and K+ into the cell against their respective concentration gradients, consuming ATP in the process (主动转运)?

  1. Sodium-potassium adenosine triphosphatase pump (Na+/K+-ATPase 钠钾泵) Correct answer.
  2. Voltage-gated sodium channel facilitated diffusion (电压门控钠通道易化扩散)
  3. Simple lipid bilayer passive diffusion (简单扩散)
  4. Potassium leak channel passive efflux (钾漏通道被动外流)

Explanation

Primary active transport (原发性主动转运) moves ions across the plasma membrane against electrochemical gradients using energy directly derived from ATP hydrolysis. The Na+/K+-ATPase pump expels 3 Na+ ions from the intracellular compartment in exchange for importing 2 K+ ions per ATP molecule hydrolyzed, maintaining resting membrane potential and cell volume.

Question 10Medical biology, diagnostic evidence and sample interpretation

During the action potential of ventricular cardiac working myocytes (心室肌动作电位), which ionic current is primarily responsible for the characteristic Phase 2 plateau (2期平台期)?

  1. Fast inward Na+ current via Nav1.5 channels (INa)
  2. Inward Ca2+ current via L-type calcium channels (ICa-L) balanced by delayed rectifier outward K+ current (IK) Correct answer.
  3. Transient outward K+ current (Ito)
  4. Inward rectifier K+ current maintaining resting potential (IK1)

Explanation

Phase 2 (plateau phase / 平台期) of the ventricular cardiac action potential is characterized by a balance between the slow inward flow of Ca2+ through L-type calcium channels (ICa-L) and the outward flow of K+ through delayed rectifier potassium channels (IK). This prolonged plateau prolongs the effective refractory period (ERP), preventing tetanic cardiac contraction.

Question 11Clinical pharmacy review, counseling and safe escalation

A 58-year-old male with dyslipidemia is prescribed Atorvastatin (阿托伐他汀, 20 mg PO daily). During routine patient monitoring, what critical adverse drug reaction (ADR) warrants immediate baseline and follow-up measurement of Serum Creatine Kinase (CK / 肌酸激酶)?

  1. Acute angle-closure glaucoma
  2. Agranulocytosis and leukopenia
  3. Statin-induced myopathy, myalgia, or life-threatening Rhabdomyolysis (横纹肌溶解症) Correct answer.
  4. Systemic lupus erythematosus

Explanation

Statins (HMG-CoA reductase inhibitors) carry the risk of Statin-Associated Muscle Symptoms (SAMS), ranging from benign myalgia to severe myositis and fatal Rhabdomyolysis (横纹肌溶解症). If a patient complains of unexplained muscle pain, tenderness, weakness, or brown-colored urine, serum Creatine Kinase (CK) must be checked immediately. A CK elevation >10x the upper limit of normal (ULN) warrants immediate cessation of statin therapy to prevent myoglobinuric acute renal failure.

Question 12Clinical pharmacy review, counseling and safe escalation

In the long-term maintenance and controller management of Chronic Persistent Bronchial Asthma, which drug class represents the foundational first-line anti-inflammatory cornerstone therapy across all age groups?

  1. Inhaled Corticosteroids (ICS / 吸入性糖皮质激素, e.g., Budesonide, Fluticasone). Correct answer.
  2. Short-Acting beta2-Agonists (SABA, e.g., Albuterol/Salbutamol) taken four times daily on a scheduled basis alone.
  3. Oral Antibacterials (e.g., Azithromycin) prescribed continuously for 5 years.
  4. Systemic High-Dose Intravenous Epinephrine administered monthly.

Explanation

Bronchial asthma is fundamentally a chronic airway inflammatory disease. Inhaled Corticosteroids (ICS / 吸入糖皮质激素, such as Budesonide, Fluticasone propionate, Beclomethasone) are the most effective anti-inflammatory medications available and form the first-line foundational controller therapy (抗炎基础药物). Monotherapy with regular scheduled SABAs is no longer recommended because it fails to treat airway inflammation and increases the risk of severe exacerbations and asthma mortality.

Question 13Dispensing systems, medication reconciliation and error prevention

A pharmacist sees ceftriaxone and calcium gluconate ordered through the same IV line for a 2-month-old infant. Which intervention correctly addresses the ceftriaxone-calcium incompatibility?

  1. Do not mix or simultaneously co-infuse them in the same line; outside the neonatal contraindication, sequential administration may be possible after thorough line flushing under the product instructions. Correct answer.
  2. Calcium gluconate acts as an enzyme that oxidizes ceftriaxone into gaseous chlorine.
  3. Ceftriaxone irreversibly degrades calcium ions into elemental metallic calcium.
  4. The combination causes spontaneous combustion inside intravenous infusion tubing.

Explanation

Ceftriaxone can precipitate with IV calcium-containing solutions. Ceftriaxone is contraindicated in neonates aged 28 days or younger who require calcium-containing IV treatment. In patients older than 28 days, the products must not be mixed or administered simultaneously through the same line, but they may be administered sequentially when the line is thoroughly flushed with compatible fluid and the applicable product instructions are followed. A 2-month-old is not automatically subject to the neonatal absolute contraindication.

Question 14Dispensing systems, medication reconciliation and error prevention

Under High-Alert Medication (高警示药品 / 高危药品) management guidelines in Chinese hospital pharmacies, which concentrated electrolyte solution carries catastrophic risk of fatal cardiac arrest if administered via direct, rapid un-diluted intravenous push?

  1. 0.9% Isotonic Sodium Chloride Injection
  2. 10% Potassium Chloride Injection (10% 氯化钾注射液) Correct answer.
  3. 5% Dextrose Injection
  4. Compound Sodium Lactate Solution

Explanation

10% Potassium Chloride Injection (10%氯化钾注射液) is a top-tier Class A High-Alert Medication (高危药品/高警示药品). Direct, undiluted intravenous bolus injection (静脉推注) produces sudden, massive hyperkalemic depolarization of the myocardium, triggering immediate refractory cardiac arrest and death. Clinical practice guidelines strictly mandate: (1) Concentrated KCl must NEVER be administered by direct IV push; (2) It must be diluted into isotonic infusions (potassium concentration must not exceed 0.3% / 40 mmol/L in peripheral lines); (3) Stored in dedicated locked cabinets with high-alert warning labels.

Question 15Evidence appraisal, calculations and pharmacy resource decisions

In hospital pharmacy inventory management, what is the Economic Order Quantity (EOQ / Formule de Wilson) used to determine, and how does the ABC analysis classify pharmaceutical inventory?

  1. EOQ determines the optimal order size that minimizes the sum of ordering costs and inventory holding/carrying costs; ABC analysis stratifies stock by annual consumption value (Class A = ~10–20% of items accounting for ~70–80% of total budget) Correct answer.
  2. EOQ calculates drug expiration dates; ABC analysis classifies drugs alphabetically by brand name
  3. EOQ determines the lethal dose 50 of toxic waste; ABC analysis sorts medicines by tablet shape
  4. EOQ calculates nurse salary deductions; ABC analysis sorts products by package weight

Explanation

The Wilson formula calculates the Economic Order Quantity: EOQ = sqrt((2 × Annual Demand × Ordering Cost) / Holding Cost per unit). ABC analysis applies Pareto's 80/20 principle to hospital pharmacy management: Class A items (high financial value, ~70–80% of expenditure, ~10–20% of line items) receive rigorous daily inventory control; Class B items (intermediate, ~15–20% value); Class C items (low financial value, ~5–10% value, ~60–70% of line items).

Question 16Pharmacy qualification roles, scientific references and local duties

In clinical pharmacy and patient safety, what is Medication Reconciliation (Conciliation des traitements médicamenteux / Medication reconciliation), and at what clinical transition points should it be systematically performed?

  1. A formal multidisciplinary process where the clinical pharmacist compiles the exhaustive Best Possible Medication History (BPMH) and compares it with active hospital prescriptions to detect and intercept unintended discrepancies, omissions, and duplications at hospital admission, intra-hospital transfer, and discharge Correct answer.
  2. A billing audit performed by hospital accounting at patient discharge
  3. Verification that the brand names match the hospital formulary exclusively
  4. A laboratory test measuring all drug concentrations in blood simultaneously

Explanation

Medication reconciliation (conciliation médicamenteuse) is a formalized patient safety process led by clinical pharmacists. By interviewing the patient, family, community pharmacist, and attending physician, the pharmacist establishes the Best Possible Medication History (BPMH / Bilan Médicamenteux Optimisé) and cross-references it with current hospital orders, identifying and correcting unintended discrepancies (omitted chronic therapies, dosing errors, duplicates) at admission, ward transfer, and discharge.

Question 17Pharmacodynamic targets, class effects and therapeutic limits

In the structure-activity relationships (SAR) of 1,4-Dihydropyridine Calcium Channel Blockers (1,4-DHP CCBs, such as Nifedipine and Amlodipine), which structural feature is essential for maintaining high vascular L-type Ca2+ channel antagonistic activity?

  1. The 1,4-dihydropyridine ring core with an unsubstituted nitrogen atom (-NH-), ester groups at C3 and C5, and an ortho- or meta-substituted phenyl ring at C4. Correct answer.
  2. A fully oxidized pyridine ring with a quaternary pyridinium nitrogen.
  3. A bulky triphenylmethyl group attached to the C2 position.
  4. A free carboxylate group at C3 and a primary amine at C5.

Explanation

Key SAR principles of 1,4-DHP calcium channel blockers include: (1) The 1,4-dihydropyridine ring is essential (oxidation to a pyridine ring destroys activity); (2) The nitrogen atom at position 1 must remain unsubstituted (-NH-); (3) Ester groups at positions 3 and 5 are mandatory (asymmetric esters optimize vascular selectivity, e.g., Amlodipine); (4) A phenyl ring at position C4 with ortho- or meta-electron-withdrawing substituents (-NO2, -Cl) ensures the phenyl ring is oriented perpendicular to the DHP plane, maximizing receptor binding.

Question 18Pharmacodynamic targets, class effects and therapeutic limits

Which of the following oral antidiabetic drug classes exerts its glucose-lowering effect by selectively inhibiting renal sodium-glucose cotransporter-2 (SGLT2), promoting urinary glucose excretion (glucosuria), and providing proven cardiovascular and renal protection?

  1. Sulfonylureas (e.g., Glimepiride / 格列美脲)
  2. SGLT2 Inhibitors (e.g., Empagliflozin / 恩格列净, Dapagliflozin / 达格列净) Correct answer.
  3. Thiazolidinediones (e.g., Pioglitazone / 吡格列酮)
  4. Alpha-Glucosidase Inhibitors (e.g., Acarbose / 阿卡波糖)

Explanation

SGLT2 Inhibitors (钠-葡萄糖协同转运蛋白2抑制剂, 'Gliflozins' such as Empagliflozin and Dapagliflozin) act on the SGLT2 cotransporter located in the proximal renal tubules, blocking glucose and sodium reabsorption. This increases urinary excretion of glucose (50–80 g/day), lowering blood glucose in an insulin-independent manner, while promoting modest weight loss, blood pressure reduction, and robust reductions in heart failure hospitalizations and chronic kidney disease progression.

Question 19Pharmacodynamic targets, class effects and therapeutic limits

Regarding the pharmacology of oral anticoagulants and antiplatelet drugs, which pairing correctly matches the drug with its molecular mechanism of action and specific clinical monitoring/reversal agent?

  1. Warfarin: Direct Factor Xa inhibitor; monitored by aPTT; reversed by protamine sulfate.
  2. Aspirin: Reversible P2Y12 receptor antagonist; monitored by INR; reversed by idarucizumab.
  3. Clopidogrel: Irreversible cyclooxygenase-1 (COX-1) inhibitor; requires CYP3A4 induction.
  4. Dabigatran (达比加群酯): Direct thrombin (Factor IIa) inhibitor; specific monoclonal antibody reversal agent is Idarucizumab (依达赛珠单抗). Correct answer.

Explanation

Dabigatran etexilate (达比加群酯) is an oral direct thrombin (Factor IIa) inhibitor. Its specific reversal agent for life-threatening bleeding or emergency surgery is Idarucizumab (依达赛珠单抗), a humanized Fab antibody fragment that binds free and thrombin-bound dabigatran with 350-fold higher affinity than thrombin. In contrast: Warfarin inhibits Vitamin K Epoxide Reductase (VKORC1), monitored by INR, reversed by Vitamin K1 / Prothrombin Complex Concentrate (PCC); Aspirin irreversibly inhibits COX-1; Clopidogrel is an irreversible P2Y12 ADP receptor blocker activated by CYP2C19.

Question 20Pharmacodynamic targets, class effects and therapeutic limits

In the clinical management of severe acute Opioid Toxicity / Overdose (e.g., Morphine, Fentanyl, Heroin intoxication presenting with coma, pinpoint pupils, and respiratory depression), what is the specific competitive opioid receptor antagonist antidote?

  1. Flumazenil (氟马西尼)
  2. Pralidoxime Chloride (氯解磷定)
  3. Naloxone (纳洛酮) Correct answer.
  4. Atropine Sulfate (硫酸阿托品)

Explanation

Naloxone (纳洛酮) is a pure, competitive opioid receptor antagonist that binds with high affinity to mu, kappa, and delta opioid receptors, displacing opioid agonists without producing intrinsic agonist activity. It rapidly reverses opioid-induced coma, respiratory depression, and miosis within 1–2 minutes of intravenous administration. Because naloxone's duration of action (30–90 min) is shorter than that of long-acting opioids (such as methadone or morphine sustained-release), repeated doses or continuous IV infusion may be required.

Question 21Pharmacodynamic targets, class effects and therapeutic limits

In solid organ transplant immunosuppression, which of the following statements regarding Calcineurin Inhibitors (CNIs: Cyclosporine / 环孢素 and Tacrolimus / 他克莫司) is TRUE?

  1. They have wide therapeutic windows and do not require blood concentration monitoring.
  2. They cause zero nephrotoxicity and can be administered at arbitrary dosages in renal failure.
  3. They inhibit calcineurin phosphatase to block Interleukin-2 (IL-2) gene transcription in T-lymphocytes; both possess narrow therapeutic indexes and require routine Therapeutic Drug Monitoring (TDM) due to nephrotoxicity and neurotoxicity. Correct answer.
  4. They act as monoclonal antibodies targeting CD20 on mature B-lymphocytes.

Explanation

Cyclosporine and Tacrolimus (FK506) are Calcineurin Inhibitors (CNIs / 钙调磷酸酶抑制剂). They bind to intracellular immunophilins (cyclophilin and FKBP-12, respectively), inhibiting calcineurin phosphatase and blocking the dephosphorylation and nuclear translocation of NFAT, thereby suppressing Interleukin-2 (IL-2) gene transcription and T-cell activation. Both CNIs have narrow therapeutic windows, high inter-individual pharmacokinetic variability, and significant nephrotoxicity/neurotoxicity, requiring routine Therapeutic Drug Monitoring (TDM) of whole blood trough concentrations (C0).

Question 22Pharmacodynamic targets, class effects and therapeutic limits

What is the primary pharmacological and clinical distinction between Non-Selective NSAIDs (e.g., Ibuprofen, Diclofenac, Indomethacin) and Selective Cyclooxygenase-2 (COX-2) Inhibitors (e.g., Celecoxib / 塞来昔布)?

  1. Non-selective NSAIDs cause high cardiovascular thrombotic events while having zero gastrointestinal side effects.
  2. Selective COX-2 inhibitors selectively inhibit inducible inflammatory COX-2 while sparing gastroprotective COX-1, resulting in significantly lower gastrointestinal ulceration/bleeding risks, but potential prothrombotic cardiovascular risk. Correct answer.
  3. Selective COX-2 inhibitors are exclusively available as intravenous general anesthetics.
  4. Non-selective NSAIDs stimulate gastric prostaglandin synthesis, preventing all peptic ulcers.

Explanation

Relative COX-2 selectivity can reduce some COX-1-related gastrointestinal effects compared with suitable nonselective comparators, but it does not eliminate gastrointestinal, renal or cardiovascular risk. Actual drug, exposure and patient conditions matter. This class mechanism is not a recommendation that every patient should receive a selective agent.

Question 23Pharmacodynamic targets, class effects and therapeutic limits

In targeted oncology therapeutics, which monoclonal antibody targets the Human Epidermal Growth Factor Receptor 2 (HER2/neu / ErbB2) extracellular domain and mandates routine echocardiographic monitoring of Left Ventricular Ejection Fraction (LVEF) due to potential Cardiotoxicity?

  1. Rituximab (利妥昔单抗)
  2. Bevacizumab (贝伐珠单抗)
  3. Cetuximab (西妥昔单抗)
  4. Trastuzumab (曲妥珠单抗) Correct answer.

Explanation

Trastuzumab (曲妥珠单抗 / Herceptin) is a humanized IgG1 monoclonal antibody that selectively binds to subdomain IV of the extracellular domain of the HER2 (ErbB2) receptor, inhibiting downstream HER2 signaling and mediating antibody-dependent cellular cytotoxicity (ADCC) in HER2-positive breast and gastric cancers. A major clinical safety concern is Cardiotoxicity (decrease in LVEF and potential heart failure), necessitating baseline and periodic (e.g., every 3 months) echocardiographic or MUGA monitoring of LVEF.

Question 24Pharmacodynamic targets, class effects and therapeutic limits

Macrolide antibacterials (e.g., Azithromycin / 阿奇霉素, Clarithromycin / 克拉霉素, Erythromycin / 红霉素) bind to the 50S ribosomal subunit to inhibit protein synthesis. Which clinical feature and adverse effect profile is characteristic of the macrolide class?

  1. Broad coverage of atypical respiratory pathogens (Mycoplasma pneumoniae, Chlamydia, Legionella), gastrointestinal motilin receptor stimulation, strong CYP3A4 inhibition (by clarithromycin/erythromycin), and potential QT prolongation. Correct answer.
  2. Complete coverage of Pseudomonas aeruginosa with zero gastrointestinal effects.
  3. Rapid destruction of bacterial cell wall peptidoglycan cross-links causing red man syndrome.
  4. Selective bactericidal lysis of anaerobic Clostridium difficile without altering gut flora.

Explanation

Macrolides (大环内酯类) bind reversibly to the 50S ribosomal subunit, inhibiting translocation. Characteristics: (1) Excellent activity against atypical pathogens (肺炎支原体, 衣原体, 军团菌); (2) Prokinetic stimulation of gastrointestinal motilin receptors causing abdominal cramps and diarrhea; (3) Strong inhibition of hepatic CYP3A4 (Clarithromycin and Erythromycin, whereas Azithromycin has minimal CYP inhibition); (4) Dose-dependent prolongation of the cardiac QT interval with potential for Torsades de Pointes (TdP).

Question 25Pharmacodynamic targets, class effects and therapeutic limits

Which of the following systemic Antifungal Agents acts by inhibiting the fungal enzyme 1,3-beta-D-glucan synthase to disrupt cell wall synthesis, and is primarily indicated for invasive candidiasis and refractory invasive aspergillosis?

  1. Fluconazole (氟康唑)
  2. Amphotericin B (两性霉素B)
  3. Caspofungin (卡泊芬净 / Echinocandin class) Correct answer.
  4. Terbinafine (特比萘芬)

Explanation

Echinocandins (棘白菌素类, e.g., Caspofungin / 卡泊芬净, Micafungin / 米卡芬净, Anidulafungin) are non-competitive inhibitors of the fungal enzyme 1,3-beta-D-glucan synthase. Because beta-(1,3)-D-glucan is a major structural polysaccharide in fungal cell walls and is completely absent in mammalian cells, echinocandins exhibit selective fungicidal activity against Candida species and fungistatic activity against Aspergillus with low mammalian toxicity.

Question 26Pharmacodynamic targets, class effects and therapeutic limits

What is the primary pharmacological difference between First-Generation H1-Antihistamines (e.g., Diphenhydramine / 苯海拉明, Chlorpheniramine / 氯苯那敏) and Second-Generation H1-Antihistamines (e.g., Loratadine / 氯雷他定, Cetirizine / 西替利嗪)?

  1. First-generation agents readily cross the blood-brain barrier (BBB) and block central H1 and muscarinic receptors, causing significant sedation, drowsiness, and anticholinergic effects (dry mouth, urinary retention), whereas second-generation agents are peripherally selective with minimal central sedation. Correct answer.
  2. Second-generation agents cause profound CNS sedation and are used exclusively as general anesthetics.
  3. First-generation agents have no peripheral antihistaminic activity whatsoever.
  4. Second-generation agents irreversibly stimulate gastric acid secretion via H2 receptors.

Explanation

First-generation H1-antihistamines (一代抗组胺药) are highly lipophilic, readily cross the blood-brain barrier, and non-selectively block central H1 receptors (causing sedation, drowsiness, impaired psychomotor performance) and muscarinic receptors (causing anticholinergic dry mouth, blurred vision, constipation, urinary retention). Second-generation H1-antihistamines (二代抗组胺药, e.g., Loratadine, Cetirizine, Fexofenadine) have lower lipophilicity, are substrates for P-glycoprotein at the BBB, and selectively bind peripheral H1 receptors, producing effective antiallergic action with minimal central sedation.

Question 27Pharmacodynamic targets, class effects and therapeutic limits

In the pharmacological management of stable Chronic Obstructive Pulmonary Disease (COPD / 慢性阻塞性肺疾病), Tiotropium Bromide (噻托溴铵) represents a Long-Acting Muscarinic Antagonist (LAMA). What is its primary therapeutic mechanism in improving lung function and reducing exacerbations?

  1. Stimulating bronchial beta2-adrenergic receptors to increase intracellular cAMP.
  2. Direct chemical lysis of DNA fibers in purulent sputum.
  3. Selective, long-lasting competitive antagonism of muscarinic M3 receptors in airway smooth muscle, inhibiting acetylcholine-mediated bronchoconstriction and mucus hypersecretion. Correct answer.
  4. Systemic immunosuppression by depleting airway alveolar macrophages.

Explanation

Tiotropium Bromide (噻托溴铵) is a Long-Acting Muscarinic Antagonist (LAMA / 长效抗胆碱药). It competitively inhibits muscarinic acetylcholine receptors (specifically the M3 receptor subtype) on bronchial smooth muscle and submucosal glands. By blocking parasympathetic cholinergic tone (the primary bronchoconstrictor mechanism in human airways), tiotropium provides sustained bronchodilation (>24 hours), decreases airway resistance, improves dynamic hyperinflation, and reduces COPD exacerbation frequency.

Question 28Pharmacodynamic targets, class effects and therapeutic limits

Which of the following antiviral agents acts as an Influenza Neuraminidase Inhibitor (神经氨酸酶抑制剂) that prevents the release and dissemination of newly formed progeny virions from infected host cells, and is most clinically effective when initiated within 48 hours of symptom onset?

  1. Oseltamivir (奥司他韦) Correct answer.
  2. Acyclovir (阿昔洛韦)
  3. Entecavir (恩替卡韦)
  4. Sofosbuvir (索磷布韦)

Explanation

Oseltamivir (奥司他韦 / Tamiflu) is an oral prodrug that is hydrolyzed by hepatic esterases into its active carboxylate metabolite. It selectively inhibits the influenza viral surface enzyme Neuraminidase (NA / 神经氨酸酶) in both Influenza A and B viruses. By preventing the enzymatic cleavage of terminal sialic acid residues on host cell surfaces, oseltamivir traps budding viral progeny on the host membrane, preventing viral release and spread. Clinical trials show that initiating therapy within 48 hours of symptom onset significantly shortens illness duration and reduces complications.

Question 29Pharmacodynamic targets, class effects and therapeutic limits

Regarding the anatomical sites of action and electrolyte disturbance profiles of Diuretic Medications, which statement correctly contrasts Loop Diuretics (e.g., Furosemide / 呋塞米) with Thiazide Diuretics (e.g., Hydrochlorothiazide / 氢氯噻嗪)?

  1. Loop diuretics act on the distal convoluted tubule and cause hypercalcemia; thiazides act on the collecting duct and cause hyperkalemia.
  2. Loop diuretics inhibit the Na+-K+-2Cl- cotransporter in the thick ascending limb of the loop of Henle and promote urinary calcium excretion (causing hypocalcemia/hypokalemia), whereas Thiazides inhibit the Na+-Cl- cotransporter in the distal convoluted tubule and reduce urinary calcium excretion (causing hypercalcemia/hypokalemia). Correct answer.
  3. Loop diuretics increase serum potassium while thiazide diuretics cause severe metabolic acidosis.
  4. Thiazides are potent loop diuretics with zero effect on sodium or chloride reabsorption.

Explanation

Key differences between loop and thiazide diuretics: (1) Loop Diuretics (Furosemide, Torsemide) inhibit the Na+-K+-2Cl- symporter in the thick ascending limb of Henle's loop, dissipating the medullary osmotic gradient; they cause loss of Na+, K+, Cl-, Mg2+, and Ca2+ (hypocalcemia and hypokalemia); (2) Thiazide Diuretics (Hydrochlorothiazide, Indapamide) inhibit the Na+-Cl- cotransporter in the early distal convoluted tubule; compensatory parathyroid/tubular mechanics enhance calcium reabsorption, causing hypokalemia, hyponatremia, and hypercalcemia (high calcium retention, beneficial in osteopenia).

Question 30Pharmacodynamic targets, class effects and therapeutic limits

A clinical pharmacist performing medication reconciliation for a 65-year-old male with NYHA Class III Heart Failure and Type 2 Diabetes notices an order for Rosiglitazone (罗格列酮) or Pioglitazone (吡格列酮). Why should the pharmacist intervene to discontinue this Thiazolidinedione (TZD)?

  1. TZDs act as PPAR-gamma agonists that increase renal sodium and fluid reabsorption, inducing fluid retention, peripheral edema, and acute exacerbation of Congestive Heart Failure (contraindicated in NYHA Class III/IV heart failure). Correct answer.
  2. TZDs cause immediate destruction of cardiac pacemaker cells.
  3. TZDs irreversibly chelate insulin molecules in the bloodstream.
  4. TZDs cause instantaneous acute renal cortical necrosis within 5 minutes.

Explanation

Thiazolidinediones (TZDs / 噻唑烷二酮类, e.g., Pioglitazone, Rosiglitazone) are PPAR-gamma agonists that improve peripheral insulin sensitivity. However, PPAR-gamma activation in the renal collecting tubules upregulates epithelial sodium channels (ENaC), leading to increased renal sodium and water retention. This causes peripheral edema, plasma volume expansion, and can precipitate or worsen congestive heart failure. Consequently, TZDs carry black-box warnings and are strictly contraindicated in patients with symptomatic NYHA Class III or IV heart failure.

Question 31Pharmacokinetics, therapeutic monitoring and explicit calculation models

A single intravenous bolus dose of 500 mg of an antibacterial drug is administered to an adult patient. Blood sampling shows an elimination rate constant k = 0.1386 h^-1 and an initial plasma concentration extrapolated to zero time C0 = 25 mg/L. Assuming a one-compartment pharmacokinetic model, what are the drug's elimination half-life (t_1/2) and apparent Volume of Distribution (Vd)?

  1. t_1/2 = 2.5 hours, Vd = 10 L
  2. t_1/2 = 10 hours, Vd = 50 L
  3. t_1/2 = 7.2 hours, Vd = 12.5 L
  4. t_1/2 = 5.0 hours, Vd = 20 L Correct answer.

Explanation

Using the supplied one-compartment first-order model, half-life is ln(2)/0.1386, approximately five hours, and apparent volume is 500 mg divided by 25 mg/L, giving twenty litres. These are model quantities rather than a new prescription or a literal anatomical volume. The assumptions and measured timing must fit before using such a model clinically.

Question 32Pharmacokinetics, therapeutic monitoring and explicit calculation models

Which of the following routes of drug administration predominantly bypasses the Hepatic First-Pass Effect (肝脏首过消除) before entering the systemic arterial circulation?

  1. Conventional oral swallowed tablet entering the gastrointestinal tract.
  2. Upper rectal administration with suppository placed near the superior rectal vein.
  3. Sublingual (舌下给药) administration absorbed directly via the sublingual venous plexus into the superior vena cava. Correct answer.
  4. Jejunal enteric tube administration into the mesenteric venous circulation.

Explanation

Sublingual administration (舌下给药) allows the active drug to be rapidly absorbed across the thin sublingual mucosa directly into the sublingual veins and internal jugular vein, emptying into the superior vena cava directly into the systemic circulation, completely bypassing hepatic portal circulation and first-pass hepatic metabolism (首过消除). Similarly, transdermal, intravenous, inhalation, and lower rectal (middle/inferior rectal veins) administration bypass hepatic first-pass metabolism.

Question 33Pharmacokinetics, therapeutic monitoring and explicit calculation models

In a two-compartment open pharmacokinetic model (二室开放模型) following an intravenous bolus injection, how are the initial rapid decline phase (alpha-phase) and the subsequent slow terminal decline phase (beta-phase) of the plasma concentration-time curve characterized?

  1. alpha-phase represents renal excretion; beta-phase represents gastrointestinal absorption.
  2. alpha-phase represents protein unbinding; beta-phase represents receptor dissociation.
  3. alpha-phase represents biliary recycling; beta-phase represents pulmonary exhalation.
  4. alpha-phase represents the rapid Distribution Phase (分布相); beta-phase represents the post-distribution Elimination Phase (消除相). Correct answer.

Explanation

The conventional labels describe an early distribution-dominated decline and a later terminal postdistribution decline in the supplied two-compartment model. The terminal rate is a hybrid system parameter rather than automatically the microscopic elimination rate constant alone. Distribution and elimination can occur concurrently, so the phase names do not mean only one process exists at each time.

Question 34Pharmacokinetics, therapeutic monitoring and explicit calculation models

Which of the following pharmaceutical agents acts as a potent Cytochrome P450 3A4 (CYP3A4) Enzyme Inducer (肝药酶诱导剂), significantly accelerating the metabolism and decreasing the plasma concentrations of co-administered oral contraceptives, cyclosporine, and statins?

  1. Ketoconazole (酮康唑)
  2. Rifampin (Rifampicin / 利福平) Correct answer.
  3. Clarithromycin (克拉霉素)
  4. Grapefruit juice (西柚汁 / 葡萄柚汁)

Explanation

Rifampicin can induce relevant metabolic and transport pathways and reduce exposure to susceptible coadministered medicines after the induction develops. The effect depends on the drug, timing and patient context. It is not proof that every medicine has the same interaction or that an unsupervised fixed dose increase is appropriate.

Question 35Pharmacokinetics, therapeutic monitoring and explicit calculation models

In the pharmacological management of Parkinson's Disease (帕金森病), why is Levodopa (左旋多巴) almost universally formulated in fixed combination with Carbidopa (卡比多巴) or Benserazide (苄丝肼)?

  1. Carbidopa crosses the blood-brain barrier to directly activate striatal D2 dopamine receptors.
  2. Carbidopa and benserazide are peripheral DOPA Decarboxylase Inhibitors (外周多巴脱羧酶抑制剂) that do not cross the blood-brain barrier, preventing premature peripheral degradation of levodopa into dopamine, thereby boosting brain delivery and reducing peripheral adverse effects (nausea, vomiting, tachycardia). Correct answer.
  3. Carbidopa acts as a centrally acting anticholinergic that cures resting tremors.
  4. Benserazide selectively destroys Lewy bodies inside the substantia nigra.

Explanation

Levodopa readily crosses the blood-brain barrier (BBB) via large neutral amino acid transporters, whereas dopamine cannot cross the BBB. If levodopa is given alone, >95% is decarboxylated peripherally by aromatic L-amino acid decarboxylase (DOPA decarboxylase / DDC) into dopamine in the bloodstream, causing severe nausea, vomiting, orthostatic hypotension, and arrhythmias while leaving <1% to enter the brain. Co-administering peripheral DDC inhibitors (Carbidopa or Benserazide) blocks peripheral decarboxylation without crossing the BBB, increasing brain levodopa bioavailability by 4- to 5-fold and mitigating peripheral side effects.

Question 36Pharmacokinetics, therapeutic monitoring and explicit calculation models

A 72-year-old female inpatient (weight 50 kg, height 155 cm) has a stable serum creatinine (SCr) of 1.8 mg/dL (159 μmol/L). Using the standard Cockcroft-Gault equation (CrCl = [(140 - age) × weight (kg)] / [72 × SCr (mg/dL)] × 0.85 [if female]), what is her estimated Creatinine Clearance (CrCl), and what dosage strategy is required for renally eliminated drugs like Vancomycin?

  1. CrCl ≈ 65 mL/min; standard full dose without adjustment.
  2. CrCl ≈ 85 mL/min; dose increase by 50%.
  3. CrCl ≈ 22.3 mL/min; significant dosage reduction and/or extension of the dosing interval guided by therapeutic drug monitoring (TDM). Correct answer.
  4. CrCl ≈ 5.0 mL/min; immediate hemodialysis initiation required.

Explanation

The supplied Cockcroft-Gault model gives [(140-72)×50/(72×1.8)]×0.85, approximately twenty-two-point-three mL/min. This is an estimated creatinine clearance under the stated assumptions, not indexed GFR or proof of chronic kidney disease stage. Renally cleared therapy needs an individualized current monitoring and dosing plan, not an automatic fixed trough-only adjustment.

Question 37Dosage forms, formulation behavior and responsible preparation

Surfactants are classified according to the Hydrophilic-Lipophilic Balance (HLB) value. Which of the following non-ionic surfactants has a LOW HLB value (typically 1.8–8.6), is lipophilic, and is primarily used as an emulsifying agent for Water-in-Oil (W/O) emulsions?

  1. Polysorbate 80 (Tween 80 / 吐温80, HLB ≈ 15.0)
  2. Sodium Lauryl Sulfate (SDS / 十二烷基硫酸钠, HLB ≈ 40)
  3. Polyoxyethylene castor oil (Cremophor EL, HLB ≈ 13.5)
  4. Sorbitan fatty acid esters (Span series / 司盘类, such as Span 80, HLB ≈ 4.3) Correct answer.

Explanation

Surfactants with low HLB values (HLB 3–8) are predominantly lipophilic and favor the formation of Water-in-Oil (W/O / 油包水型) emulsions; the Span series (司盘类, sorbitan fatty acid esters) have low HLB values (e.g., Span 80 HLB = 4.3). Conversely, surfactants with high HLB values (HLB 8–16), such as the Tween series (吐温类, polysorbates, e.g., Tween 80 HLB = 15.0), are hydrophilic and act as Oil-in-Water (O/W / 水包油型) emulsifiers or solubilizers.

Question 38Dosage forms, formulation behavior and responsible preparation

In targeted drug delivery systems (靶向给药系统), what is the defining mechanism of 'Passive Targeting' (被动靶向制剂) observed with conventional liposomes and polymeric nanoparticles (size 100–200 nm)?

  1. Natural uptake and sequestration by the mononuclear phagocyte system (MPS / RES) in the liver and spleen, or extravasation through leaky tumor vasculature via the Enhanced Permeability and Retention (EPR) effect. Correct answer.
  2. Conjugation of monoclonal antibodies or folic acid ligands to bind overexpressed cancer cell membrane receptors.
  3. Application of external magnetic fields or focused ultrasound to concentrate microbubbles at the target anatomical site.
  4. Temperature-sensitive phase transition triggered precisely at 42°C in hyperthermic tissues.

Explanation

Conventional passive targeting can involve uptake by the mononuclear phagocyte system or accumulation associated with suitable vascular and tissue properties. The effect depends on carrier, patient and disease conditions; it is not a guarantee that every liposome or every tumor receives an identical selective concentration. A distribution mechanism does not establish clinical efficacy by itself.

Question 39Dosage forms, formulation behavior and responsible preparation

In the formulation of Ophthalmic Solutions (Eye Drops / 滴眼剂), why are viscosity-increasing polymers such as Methylcellulose (MC) or Hydroxypropyl Methylcellulose (HPMC) routinely incorporated?

  1. To accelerate rapid drainage through the nasolacrimal duct into the nasal cavity.
  2. To induce immediate corneal epithelial desquamation for deeper penetration.
  3. To prolong precorneal residence time, reduce lacrimal drainage loss, and enhance ocular bioavailability. Correct answer.
  4. To permanently acidify the tear film to pH 2.0 to inhibit fungal proliferation.

Explanation

Instilled eye drops are rapidly cleared by reflex blinking and nasolacrimal drainage (normal tear turnover drains 80%–90% of instilled volume within 1–2 minutes). Adding hydrophilic viscosity-enhancing polymers (such as Methylcellulose MC, HPMC, PVA, or Carbomer) increases formulation viscosity to an optimal range of 4.0–5.0 mPa·s, slowing drainage, extending precorneal contact time, and enhancing corneal drug absorption.

Question 40Dosage forms, formulation behavior and responsible preparation

In pharmaceutical formulation technology, what is the primary mechanism by which Solid Dispersions (固体分散体) prepared with water-soluble carriers (such as PEG 4000/6000 or Polyvinylpyrrolidone PVP) significantly enhance the dissolution rate and oral bioavailability of poorly water-soluble BCS Class II drugs?

  1. The drug is highly dispersed in an amorphous, microcrystalline, or molecular state within the hydrophilic matrix, increasing surface area and wettability while reducing crystal lattice energy. Correct answer.
  2. The carrier converts the active drug into an insoluble covalent crystalline dimer.
  3. The polymer permanently binds the drug to prevent it from dissolving in gastric juice.
  4. The carrier acts as a surfactant that increases the critical micelle concentration of bile salts by a factor of 10,000.

Explanation

Solid Dispersions (固体分散体) disperse poorly soluble hydrophobic drugs into hydrophilic polymeric carriers (such as PEG, PVP, poloxamers). This formulation technique: (1) Converts crystalline drug into an amorphous or molecularly dispersed state (eliminating crystal lattice energy barriers); (2) Dramatically reduces particle size to sub-micron levels, vastly expanding effective dissolution surface area; and (3) Enhances carrier-mediated wettability, dramatically accelerating dissolution according to the Noyes-Whitney equation.

Question 41Dosage forms, formulation behavior and responsible preparation

Which of the following chemical substances is widely utilized in Transdermal Drug Delivery Systems (TDDS / 经皮给药制剂) as a potent Chemical Penetration Enhancer (经皮吸收促进剂) that reversibly disrupts stratum corneum intercellular lipid bilayers?

  1. Magnesium Stearate (硬脂酸镁)
  2. Microcrystalline Cellulose (微晶纤维素 MCC)
  3. Azone (1-Dodecylazacycloheptan-2-one / 氮酮) and Menthol (薄荷脑) Correct answer.
  4. Cross-linked Sodium Carboxymethylcellulose (交联羧甲基纤维素钠)

Explanation

Azone (氮酮 / Laurocapram) and natural terpenes such as Menthol (薄荷脑), along with Propylene Glycol and DMSO, are classic chemical penetration enhancers (经皮吸收促进剂). Azone inserts into the lipid bilayers of the stratum corneum (角质层), disrupting their highly ordered crystalline arrangement and increasing membrane fluidity, thereby facilitating transdermal diffusion of both hydrophilic and lipophilic drugs.

Question 42Dosage forms, formulation behavior and responsible preparation

Under the Biopharmaceutics Classification System (BCS / 生物药剂学分类系统), which class represents drugs with HIGH solubility and LOW intestinal permeability, where drug absorption is primarily rate-limited by mucosal permeation?

  1. BCS Class I (I类药物)
  2. BCS Class II (II类药物)
  3. BCS Class IV (IV类药物)
  4. BCS Class III (III类药物) Correct answer.

Explanation

The BCS classifies active pharmaceutical ingredients into 4 classes based on aqueous solubility and intestinal permeability: Class I: High Solubility, High Permeability (e.g., Metoprolol); Class II: Low Solubility, High Permeability (dissolution rate-limited, e.g., Carbamazepine, Ketoconazole); Class III: High Solubility, Low Permeability (membrane permeability rate-limited, e.g., Atenolol, Cimetidine); Class IV: Low Solubility, Low Permeability (e.g., Furosemide, Paclitaxel).

Question 43Dosage forms, formulation behavior and responsible preparation

In Freeze-Drying (Lyophilization / 冷冻干燥) technology for biologicals and thermolabile injectables, what is the thermodynamic process occurring during the Primary Drying Stage (第一阶段升华干燥)?

  1. Direct sublimation of frozen ice crystals into water vapor under reduced pressure below the triple point of water. Correct answer.
  2. Boiling of liquid water at 100°C under atmospheric pressure.
  3. Chemical oxidation of water molecules using hydrogen peroxide.
  4. Thermal condensation of water vapor into liquid droplets.

Explanation

Freeze-drying (冷冻干燥 / 升华干燥) involves three distinct steps: (1) Pre-freezing: Freezing the liquid formulation below its eutectic/glass transition temperature (Tg'); (2) Primary drying (升华干燥): Operating below the triple point of water (0.01°C, 611.73 Pa) under vacuum where frozen ice sublimates directly into water vapor; (3) Secondary drying (解析干燥): Desorbing residual bound water at elevated temperature under high vacuum to reach a final moisture content <1%–3%.

Question 44Dosage forms, formulation behavior and responsible preparation

Cocoa Butter (可可豆脂) is a classic lipophilic suppository base. What is its major pharmaceutical drawback when heated above 36°C during fusion compounding?

  1. It undergoes irreversible covalent polymerization into an insoluble ceramic solid.
  2. It reacts with water to release toxic formaldehyde vapors.
  3. It exhibits polymorphic transitions (alpha, beta, beta', gamma forms) with lowered melting points (24°C–28°C), preventing solid suppository solidification at room temperature. Correct answer.
  4. It instantly neutralizes basic active pharmaceutical ingredients via irreversible saponification.

Explanation

Cocoa Butter (可可豆脂) consists of mixed triglycerides that exhibit complex polymorphism (alpha, beta, beta', gamma crystalline forms). The stable beta-crystal melts at 34°C–35°C (ideal for melting at rectal body temperature). However, if overheated above 36°C, the crystal nuclei are destroyed and it cools into metastable alpha and gamma polymorphic forms whose melting points drop to 24°C or below, causing the suppositories to remain liquid or soft at room temperature.

Question 45Dosage forms, formulation behavior and responsible preparation

In the aseptic compounding of Total Parenteral Nutrition (TPN / 全胃肠外营养 'All-in-One' 3-in-1 admixture), which physicochemical incompatibility between Calcium (Ca2+) and Inorganic Phosphate (HPO4 2-) must be strictly controlled to prevent fatal crystalline microvascular precipitation?

  1. Calcium ions reduce phosphate into poisonous phosphine gas.
  2. Phosphate catalyzes the explosive polymerization of amino acids.
  3. Calcium and phosphate ions can react to form insoluble Dibasic Calcium Phosphate (CaHPO4) precipitates; compounding pharmacists must control the [Ca2+] x [HPO4 2-] solubility product, dilute phosphate in glucose and calcium in amino acids, and add them separately. Correct answer.
  4. Calcium gluconate causes immediate rancid oxidation of lipid emulsions at 4°C.

Explanation

In TPN admixtures, Calcium (Ca2+) and Phosphate (HPO4 2-) can react to form insoluble Dibasic Calcium Phosphate (CaHPO4) or Tribasic Calcium Phosphate crystalline precipitates. Infusing microcrystals can cause fatal pulmonary capillary microembolism. Compounding safeguards: (1) Use Calcium Gluconate (which dissociates less than Calcium Chloride); (2) Ensure the molar solubility product [Ca] x [P] does not exceed established solubility curves; (3) Add phosphate first to the amino acid/glucose solution, mix thoroughly, and add calcium at the end; (4) Maintain an acidic pH (higher pH favors HPO4 2- formation).

Question 46Clinical pharmacy review, counseling and safe escalation

A patient receiving Fluoxetine (氟西汀, a Selective Serotonin Reuptake Inhibitor / SSRI) for major depressive disorder is inadvertently prescribed the Monoamine Oxidase Inhibitor (MAOI) Selegiline. What life-threatening drug-drug interaction syndrome is the patient at acute risk of developing?

  1. Severe Hypothyroidism with myxedema coma
  2. Acute Angle-Closure Glaucoma crisis
  3. Agranulocytosis and aplastic anemia
  4. Serotonin Syndrome (5-羟色胺综合征 / 5-HT综合征), characterized by hyperthermia, neuromuscular clonus, hyperreflexia, agitation, and autonomic instability. Correct answer.

Explanation

Combining SSRIs (e.g., Fluoxetine, Paroxetine, Sertraline) with Monoamine Oxidase Inhibitors (MAOIs, e.g., Selegiline, Phenelzine, Linezolid) causes massive accumulation of serotonin in the central and peripheral nervous system, triggering life-threatening Serotonin Syndrome (5-HT综合征 / 5-羟色胺综合征). Clinical manifestations include triad of neuromuscular excitation (myoclonus, hyperreflexia, rigidity), autonomic hyperactivity (hyperthermia, tachycardia, diaphoresis, labile BP), and altered mental status (agitation, delirium). A mandatory washout period of at least 5 weeks is required when switching from fluoxetine to an MAOI.

Question 47Clinical pharmacy review, counseling and safe escalation

Under the Vaughan-Williams classification of antiarrhythmic drugs, Amiodarone (胺碘酮) is classified as a Class III agent. Which of the following long-term adverse reaction profiles and organ toxicities requires systematic baseline and periodic monitoring during chronic amiodarone therapy?

  1. Pure nephrotoxicity without cardiac or endocrine involvement.
  2. Pulmonary Fibrosis (间质性肺炎/肺纤维化), Thyroid Dysfunction (hypo/hyperthyroidism), Corneal Microdeposits, and QT prolongation. Correct answer.
  3. Aplastic anemia and severe bone marrow suppression.
  4. Selective destruction of the adrenal cortex with Addisonian crisis.

Explanation

Amiodarone (胺碘酮) is a broad-spectrum Class III antiarrhythmic (potassium channel blocker that also possesses Class I, II, and IV actions). Due to its high lipophilicity and structural iodine content (37% iodine by weight), chronic accumulation causes significant multi-organ toxicities: (1) Pulmonary toxicity: Interstitial pneumonitis and fatal pulmonary fibrosis (肺间质纤维化); (2) Thyroid toxicity: Hypothyroidism (amiodarone-induced hypothyroidism, AIH) or Hyperthyroidism (AIT); (3) Ocular: Asymptomatic corneal microdeposits (角膜色素沉着); (4) Cardiac: QT prolongation and TdP risk; (5) Dermatologic: Blue-gray skin discoloration and photosensitivity.

Question 48Clinical pharmacy review, counseling and safe escalation

According to modern clinical practice guidelines for Heart Failure with reduced Ejection Fraction (HFrEF, LVEF <= 40%), which four foundational drug classes constitute the 'Four Pillars' (基础四联药物) proven to reduce cardiovascular mortality and hospitalization?

  1. Digoxin + Furosemide + Nifedipine + Hydralazine
  2. Aspirin + Clopidogrel + Atorvastatin + Warfarin
  3. Verapamil + Diltiazem + Nitroglycerin + Hydrochlorothiazide
  4. ARNI (Sacubitril/Valsartan / 沙库巴曲缬沙坦) or ACEI/ARB + Evidence-based Beta-Blocker + Mineralocorticoid Receptor Antagonist (MRA, e.g., Spironolactone / 螺内酯) + SGLT2 Inhibitor (Dapagliflozin / Empagliflozin). Correct answer.

Explanation

Guideline-Directed Medical Therapy (GDMT) for HFrEF is founded upon the 'Four Pillars' (抗心衰四大基石 / 基础四联药物): (1) ARNI (Sacubitril/Valsartan) or ACEI/ARB to inhibit neurohormonal maladaptation; (2) Evidence-based Beta-Blockers (Bisoprolol, Carvedilol, or Metoprolol Succinate); (3) Mineralocorticoid Receptor Antagonists (MRA: Spironolactone or Eplerenone); (4) SGLT2 Inhibitors (Dapagliflozin or Empagliflozin). This combination provides synergistic mortality reduction and reverses adverse ventricular remodeling.

Question 49Clinical pharmacy review, counseling and safe escalation

Which listed HLA allele is associated with an increased risk of severe carbamazepine-related cutaneous reactions in relevant ancestry populations, with testing and prescribing governed by current appropriate guidance?

  1. HLA-B*1502 allele screening (HLA-B*1502基因检测). Correct answer.
  2. TPMT (thiopurine methyltransferase) genotype assay.
  3. HER2 gene amplification testing.
  4. Factor V Leiden mutation testing.

Explanation

Carbamazepine-induced Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are strongly associated with the HLA-B*1502 allele in Han Chinese and other Southeast Asian populations. In patients carrying the HLA-B*1502 allele, the odds ratio for developing carbamazepine-induced SJS/TEN exceeds 100-fold. National guidelines and drug labels recommend mandatory or routine screening for HLA-B*1502 prior to starting carbamazepine in Han Chinese patients; if positive, carbamazepine should be avoided.

Question 50Clinical pharmacy review, counseling and safe escalation

In the standard first-line short-course anti-tuberculosis regimen (HRZE: Isoniazid, Rifampin, Pyrazinamide, Ethambutol), which drug is uniquely associated with Retrobulbar Optic Neuritis (球后视神经炎, presenting as decreased visual acuity and red-green color blindness), requiring baseline and routine visual monitoring?

  1. Isoniazid (H / 异烟肼)
  2. Rifampin (R / 利福平)
  3. Pyrazinamide (Z / 吡嗪酰胺)
  4. Ethambutol (E / 乙胺丁醇) Correct answer.

Explanation

Ethambutol (EMB / E / 乙胺丁醇) inhibits arabinosyl transferase III in the mycobacterial cell wall. Its key, dose-dependent adverse reaction is Retrobulbar Optic Neuritis (球后视神经炎), manifesting as reduced visual acuity, central scotomas, and loss of red-green color discrimination (红绿色盲). Patients on ethambutol must undergo visual acuity and color vision testing prior to initiation and periodically during therapy. The drug must be discontinued immediately if visual impairment occurs.